CVE-2026-83004: Oracle WebCenter Enterprise Capture · Improper Access Control
Affects Oracle WebCenter Enterprise CaptureSource CVE Database V5
Not known to be exploited · CVSS 7.2 High.
Data as of 30 Oct 2026, 20:25 UTC
- EPSS
- 0.1% chance of exploitation in 30 days – higher than 2% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:L/AC:H/PR:L/UI:R/S:C/C:H/I:H/A:NExploitation evidence
Disclosed: evidence found.
CVE published 15 Sep 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 30 Oct 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Oracle CorporationOracle WebCenter Enterprise Capture | Affected
| Fixed in– |
AI-suggested
Oracle has released security patches addressing this vulnerability as part of their September 2026 Critical Security Patch Update. Customers are strongly advised to apply the relevant patches without delay to mitigate this vulnerability. The affected versions are 12.2.1.4.0 and 14.1.2.0.0 of Oracle WebCenter Enterprise Capture. No additional mitigation steps are indicated beyond applying the official patches.
Description
CVE-2026-83004 is a high-severity vulnerability in Oracle WebCenter Enterprise Capture versions 12.2.1.4.0 and 14.1.2.0.0. It allows a low privileged attacker with logon access to the infrastructure to compromise the product, requiring human interaction from a third party. Successful exploitation can lead to unauthorized creation, deletion, or modification of critical data within Oracle WebCenter Enterprise Capture and may impact additional products due to scope change. The vulnerability has a CVSS 3.1 base score of 7.2, indicating significant confidentiality and integrity impacts.